Terms: = Gastric cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Clinical Outcome
21 results:
1. Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms?
Exarchou K; Kamieniarz L; Tsoli M; Victor A; Oleinikov K; Khan MS; Srirajaskanthan R; Mandair D; Grozinsky-Glasberg S; Kaltsas G; Howes N; Pritchard DM; Toumpanakis C
Endocrine; 2021 Nov; 74(2):421-429. PubMed ID: 34120313
[TBL] [Abstract] [Full Text] [Related]
2. Needle Catheter Jejunostomy in Patients Undergoing Surgery for Upper Gastrointestinal and Pancreato-Biliary cancer-Impact on Nutritional and clinical outcome in the Early and Late Postoperative Period.
Wobith M; Wehle L; Haberzettl D; Acikgöz A; Weimann A
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854177
[TBL] [Abstract] [Full Text] [Related]
3. [Relationship between morphological characteristics and prognosis of non-nasopharyneal EBV-associated carcinoma].
Yin WJ; Wu YX; Liu LY; Gong L; Lan XB; Sun WY; Su D; Ni XH
Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):209-214. PubMed ID: 30831647
[No Abstract] [Full Text] [Related]
4. Vascularizing lymph node dissection for advanced gastric cancer: A single-institution experience.
Han FH; Zhou SN; Li HM; He YL; Zhan WH
World J Gastroenterol; 2016 Apr; 22(14):3813-20. PubMed ID: 27076766
[TBL] [Abstract] [Full Text] [Related]
5. Survival benefit of greater number of lymph nodes dissection for advanced node-negative gastric cancer patients following radical gastrectomy.
He H; Shen Z; Wang X; Qin J; Sun Y; Qin X
Jpn J Clin Oncol; 2016 Jan; 46(1):63-70. PubMed ID: 26497044
[TBL] [Abstract] [Full Text] [Related]
6. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
Shen L; Zhang H; Liang L; Li G; Fan M; Wu Y; Zhu J; Zhang Z
Radiat Oncol; 2014 Dec; 9():295. PubMed ID: 25518933
[TBL] [Abstract] [Full Text] [Related]
7. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a single-center experience.
Choi MK; Kim GH; Park DY; Song GA; Kim DU; Ryu DY; Lee BE; Cheong JH; Cho M
Surg Endosc; 2013 Nov; 27(11):4250-8. PubMed ID: 23765426
[TBL] [Abstract] [Full Text] [Related]
8. CD33⁺/p-STAT1⁺ double-positive cell as a prognostic factor for stage IIIa gastric cancer.
Dong J; Li J; Liu SM; Feng XY; Chen S; Chen YB; Zhang XS
Med Oncol; 2013 Mar; 30(1):442. PubMed ID: 23307253
[TBL] [Abstract] [Full Text] [Related]
9. outcome and status of microsatellite stability in Japanese atomic bomb survivors with early gastric carcinoma.
Yamamoto M; Taguchi K; Yamanaka T; Matsuyama A; Yoshinaga K; Tsutsui S; Ishida T
Ann Surg Oncol; 2013 Mar; 20(3):798-803. PubMed ID: 23149851
[TBL] [Abstract] [Full Text] [Related]
10. Serum levels of TUBB3 correlate with clinical outcome in Chinese patients with advanced gastric cancer receiving first-line paclitaxel plus capecitabine.
Yu J; Gao J; Lu Z; Li Y; Shen L
Med Oncol; 2012 Dec; 29(5):3029-34. PubMed ID: 22766748
[TBL] [Abstract] [Full Text] [Related]
11. Safe management of anastomotic leakage after gastric cancer surgery with enteral nutrition via a nasointestinal tube.
Akashi Y; Hiki N; Nunobe S; Jiang X; Yamaguchi T
Langenbecks Arch Surg; 2012 Jun; 397(5):737-44. PubMed ID: 22382705
[TBL] [Abstract] [Full Text] [Related]
12. Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer.
Iqbal S; Goldman B; Fenoglio-Preiser CM; Lenz HJ; Zhang W; Danenberg KD; Shibata SI; Blanke CD
Ann Oncol; 2011 Dec; 22(12):2610-2615. PubMed ID: 21415234
[TBL] [Abstract] [Full Text] [Related]
13. Mucinous gastric cancer presents with more advanced tumor stage and weaker β-catenin expression than nonmucinous cancer.
Choi MG; Sung CO; Noh JH; Kim KM; Sohn TS; Kim S; Bae JM
Ann Surg Oncol; 2010 Nov; 17(11):3053-8. PubMed ID: 20645013
[TBL] [Abstract] [Full Text] [Related]
14. Operative outcome of colon interposition in the treatment of esophageal cancer: a 20-year experience.
Klink CD; Binnebösel M; Schneider M; Ophoff K; Schumpelick V; Jansen M
Surgery; 2010 Apr; 147(4):491-6. PubMed ID: 20004440
[TBL] [Abstract] [Full Text] [Related]
15. The long-term outcome of atomic bomb survivors with gastric carcinoma.
Yamamoto M; Matsuyama A; Kameyama T; Okamoto M; Okazaki J; Utsunomiya T; Tsutsui S; Ishida T
J Surg Oncol; 2009 Dec; 100(7):594-7. PubMed ID: 19731244
[TBL] [Abstract] [Full Text] [Related]
16. clinical outcome of malignant biliary obstruction caused by metastatic gastric cancer.
Migita K; Watanabe A; Yoshioka T; Kinoshita S; Ohyama T
World J Surg; 2009 Nov; 33(11):2396-402. PubMed ID: 19655195
[TBL] [Abstract] [Full Text] [Related]
17. Combined endolaparoscopic intragastric excision for gastric neoplasms.
Wong DC; Wong SK; Leung AL; Chung CC; Li MK
J Laparoendosc Adv Surg Tech A; 2009 Dec; 19(6):765-70. PubMed ID: 19645605
[TBL] [Abstract] [Full Text] [Related]
18. Initial experience with a new laparoscopic ultrasound probe for guided biopsy in the staging of upper gastrointestinal cancer.
Hassan H; Vilmann P; Sharma V; Holm J
Surg Endosc; 2009 Jul; 23(7):1552-8. PubMed ID: 19263158
[TBL] [Abstract] [Full Text] [Related]
19. Long-term clinical outcome of helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma is comparable to that of h. pylori-positive lymphoma.
Chung SJ; Kim JS; Kim H; Kim SG; Kim CW; Jung HC; Song IS
J Clin Gastroenterol; 2009 Apr; 43(4):312-7. PubMed ID: 18936712
[TBL] [Abstract] [Full Text] [Related]
20. clinical outcome of gastric cancer patients with bone marrow metastases.
Kim HS; Yi SY; Jun HJ; Lee J; Park JO; Park YS; Jang J; Kim HJ; Ko Y; Lim HY; Kang WK
Oncology; 2007; 73(3-4):192-7. PubMed ID: 18418012
[TBL] [Abstract] [Full Text] [Related]
[Next]
